DeepLife is an innovative biotechnology company focused on advancing drug discovery through the integration of deep learning and systems biology. With a team comprised of 90% PhD professionals from over 15 nationalities across the EU and US, DeepLife fosters a collaborative research environment aimed at developing state-of-the-art methods for target identification and drug repurposing. The company is dedicated to bridging the gap between computational innovation and practical therapeutic insights, empowering its multidisciplinary teams to tackle complex biological challenges and drive meaningful advancements in healthcare.